EnsoData Raises $20M Series B

MADISON, WI – June 25, 2025 – EnsoData raised $20 million in Series B financing led by Questa Capital, with participation from existing investors including Zetta Venture Partners and Venture Investors Health Fund, to accelerate adoption of their AI-powered sleep medicine solutions.

• Comprehensive AI Platform: EnsoData's technology integrates FDA-cleared clinical AI and machine learning across the complete sleep care pathway, from diagnosis to therapy, with an emphasis on usability and interoperability that positions the company for expansion into adjacent medical specialties.
  
• Addressing Major Care Gaps: The funding targets a significant healthcare problem where 80% of sleep apnea patients remain undiagnosed and only half of those diagnosed receive successful treatment, affecting an estimated 54 million Americans with sleep apnea.
• Commercial Expansion: EnsoData is scaling their commercial operations with the recent hire of Chief Commercial Officer Bobby Cockrill and plans to build a substantial US sales team to deliver their FDA-cleared AI platform that has already impacted care for over 2.5 million patients.
• Read More Here: https://www.ensodata.com/press/ensodata-raises-20m-series-b/

‍